The documentary, which will debut nationwide on PBS March 21, illustrates the full scope of his career set against the backdrop of his final years of service presiding over the nation’s response to the COVID-19 pandemic.
Cornell administrators announced May 3 that certain COVID-19 restrictions on mask use and the size of group gatherings will be eased in a manner consistent with the latest guidance from the CDC.
The pandemic will have an enormous impact on civil infrastructure, from highways and airports to dams and energy systems, says Richard Geddes, an expert on infrastructure policy.
Thomas Pepinsky, an expert on economic policy at Cornell University, discusses President Donald Trump’s decision to halt funding to the World Health Organization, and his new research: Democrats are much more likely to take active steps to combat the spread of COVID-19.
Adult vaccination rates and social determinants of health – the social and economic conditions in which families live and work – have played an important role in children’s mental health during the pandemic, according to a new study led by Weill Cornell Medicine investigators.
Researchers set out to model the probability of how often pairs of shoppers might overlap in a store – an approach that could be used to predict the transmission of COVID-19, and guide strategies to reduce its spread.
The coronavirus pandemic has challenged Cornell students, as they’ve waited for online instruction to begin April 6. But many are responding with resilience, staying sharp and taking care of others, and themselves.
Cornell has joined an amicus brief supporting Harvard and MIT's challenge of a Trump administration directive that would deny visas to international students who take only online classes this fall.
Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.
In the study, researchers at Weill Cornell Medicine and their colleagues also identified new potential treatments for COVID-19 patients and described a model for drug screening.